These fusion genes are thought to promote tumor growth by driving expression of constitutively active fusion proteins through the activation of downstream signal transduction pathways, such as phosphoinositide 3-kinase/protein kinase B (PI3K-AKT) and mitogen-activated protein kinase (MAPK) signaling cascades8–10. The gene discussed is AKT1; the disease is neoplasm.